MedTrace Logo

A Phase II Study of Parotid-gland Sparing IMRT in Patients With Midline Tumour of the Head and Neck

NCT02149602 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2014-05-29

No results posted yet for this study

Summary

This study is a phase II trial designed to test the feasibility of delivering IMRT to head and neck cancer patients with tumours arising in the midline (oropharynx and hypopharynx), and to assess possible improvement in reducing the incidence of xerostomia with bilateral superficial lobe parotid sparing IMRT.

Conditions

  • Oropharyngeal Squamous Cell Cancer
  • Hypopharyngeal Squamous Cell Cancer

Interventions

RADIATION

Intensity modulated radiotherapy

Bilateral superficial lobe parotid sparing intensity modulated radiotherapy

Sponsors & Collaborators

  • Royal Marsden NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Christopher M Nutting, FRCR · Royal Marsden NHS Foundation Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-07-31
Primary Completion
2011-11-30
Completion
2014-01-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02149602 on ClinicalTrials.gov